Definium Therapeutics, Inc. (DFTX)

SEC filing

Definium Therapeutics, Inc.

DFTX · CIK 1813814

4 · Sep 14, 2026 · Director, Chief Executive Officer Barrow Robert was granted 750K Common Shares

Director, Chief Executive Officer Barrow Robert was granted 750K Common Shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.